Assembly Biosciences FCO/Dettes

Que fait Assembly Biosciences ? Assembly Biosciences Inc is a biotechnology company based in South San Francisco, United States, specializing in the development of therapeutics for infectious diseases. The firm focuses on two primary platform programs: oral therapeutics targeting chronic hepatitis B virus (HBV) infection and oral synthetic live therapeutics designed to restore health to a dysbiotic microbiome. Its HBV program utilizes core protein allosteric modulators (CpAMs), small molecules that directly target the HBV core protein. The microbiome initiative features an integrated platform including strain identification, isolation under good manufacturing practice conditions, and the GEMICEL delivery system for targeted oral administration to the lower gastrointestinal tract. The company went public in December 2010 and employs staff dedicated to these innovative medical solutions. Assembly Biosciences est l'une des entreprises les plus populaires sur Eulerpool.